Clinical evidence for the prognostic impact of metformin in cancer patients treated with immune checkpoint inhibitors is a research paper published in International Immunopharmacology (2024). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Fundamental Research Funds for the Central Universities
Grant: 2632023TD08
National Natural Science Foundation of China
Grant: 82330119
China Pharmaceutical University
FWCI
1.97
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals